Efficacy of addition immune checkpoint inhibitors to chemotherapy as first-line treatment for small cell lung cancer patients with liver or brain metastases: a systematic review and meta-analysis.

Chen, C-R; Qi, W-X; Liu, T; Tong, X

Chen, C-R; Qi, W-X; Liu, T; Tong, X.

Affiliation

Chen CR; Department of Radiation Oncology, The First Affiliated Hospital of Qiqihar Medical College, Qiqihar, Heilongjiang Province, China. chen.chunrong@qmu.edu.cn.

Eur Rev Med Pharmacol Sci ; 26(16): 5857-5867, 2022 08.

Article in En | MEDLINE | ID: mdl-36066161

Subject(s)

Brain Neoplasms; Liver Neoplasms; Lung Neoplasms; Small Cell Lung Carcinoma; Brain Neoplasms/drug therapy; Humans; Immune Checkpoint Inhibitors/therapeutic use; Liver Neoplasms/drug therapy; Lung Neoplasms/pathology; Small Cell Lung Carcinoma/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Small Cell Lung Carcinoma / Liver Neoplasms / Lung Neoplasms Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2022 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google